2016
DOI: 10.6061/clinics/2016(08)02
|View full text |Cite
|
Sign up to set email alerts
|

Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma: Brazilian Survey

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
(10 reference statements)
0
1
0
Order By: Relevance
“…Especially in these situations, immunohistochemistry may also help in distinguishing between HCC and other adenocarcinomas (84) . HCC subtypes, some of which are already well characterized in their morphological and molecular profiles, have been described, including FLC (87) ; scirrhous hepatocellular carcinoma (88) ; steatohepatic HCC (89) ; HCC with lymphoid stroma, clear-cell variant of HCC and sarcomatous HCC (90) . On the other hand, the identification of molecular profiles by gene expression, DNA sequencing or RNA sequencing techniques or even combined approaches has brought new proposals for the classification of HCC based on genetics, highlighting, in summary, two major types:…”
Section: Hcc Anatomopathological Diagnosismentioning
confidence: 99%
“…Especially in these situations, immunohistochemistry may also help in distinguishing between HCC and other adenocarcinomas (84) . HCC subtypes, some of which are already well characterized in their morphological and molecular profiles, have been described, including FLC (87) ; scirrhous hepatocellular carcinoma (88) ; steatohepatic HCC (89) ; HCC with lymphoid stroma, clear-cell variant of HCC and sarcomatous HCC (90) . On the other hand, the identification of molecular profiles by gene expression, DNA sequencing or RNA sequencing techniques or even combined approaches has brought new proposals for the classification of HCC based on genetics, highlighting, in summary, two major types:…”
Section: Hcc Anatomopathological Diagnosismentioning
confidence: 99%